CapForce Inc.
CFOR
Get informed when a big investor buys or sells
+ FollowMarket Cap$242.67M
Close$
Share Statistics
| Market cap | $242.67 Million |
|---|---|
| Enterprise Value | $244.28 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 83.85% |
|---|---|
| Return on Assets | 71.03% |
| Return on Invested Capital | 85.75% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.21 |
| Enterprise Value to EBIT | 3.76 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Opgen Inc
3 employees
CEO: Oliver Schacht CapForce Inc. is a precision medicine company dedicated to developing and commercializing sophisticated molecular microbiology solutions. Its mission is to address life-threatening infectious diseases for patients in the United States an...